Skip to main content
Clinical Trials/ACTRN12615001103550
ACTRN12615001103550
Completed
Phase 4

Does treatment with probiotics improve the symptoms and quality of life in individuals suffering Allergic rhinitis.

Griffith University0 sites50 target enrollmentOctober 20, 2015

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Allergic rhinitis
Sponsor
Griffith University
Enrollment
50
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • For inclusion in the study participants are required to be aged between 17\-60, have a history of moderate to severe persistent Allergic rhinitis, test positive to both a skin prick test and a radio\-allergosorbent test to Bermuda (couch) grass.

Exclusion Criteria

  • Participants will be excluded from the study if they:
  • Suffer from non\-allergic rhinitis;
  • Do not test positive for on the skin prick test and radio\-allergosorbent test to Bermuda grass;
  • Have undergone treatment with systemic corticosteroids in the previous 6 months;
  • Have a history of respiratory or immune diseases;
  • Use of anti\-inflammatory or immune modulating medications;
  • Consumption of probiotics or prebiotic supplements in the previous 12 weeks;
  • Use of Antibiotics within the last 30 days;
  • Are pregnant or intending to become pregnant during the trial period;

Outcomes

Primary Outcomes

Not specified

Similar Trials